相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Therapeutic Resistance Resulting From Mutations in Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Signaling Pathways
James A. McCubrey et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2011)
Drugging the PI3 Kinome: From Chemical Tools to Drugs in the Clinic
Paul Workman et al.
CANCER RESEARCH (2010)
PTEN in Non-Alcoholic Fatty Liver Disease/Non-Alcoholic Steatohepatitis and Cancer
Marion Peyrou et al.
DIGESTIVE DISEASES (2010)
A coding-independent function of gene and pseudogene mRNAs regulates tumour biology
Laura Poliseno et al.
NATURE (2010)
Silibinin Suppresses Growth of Human Colorectal Carcinoma SW480 Cells in Culture and Xenograft through Down-regulation of β-Catenin-Dependent Signaling
Manjinder Kaur et al.
NEOPLASIA (2010)
Silibinin inhibits prostate cancer invasion, motility and migration by suppressing vimentin and MMP-2 expression
Kai-jie Wu et al.
ACTA PHARMACOLOGICA SINICA (2009)
Effects and mechanisms of silibinin on human hepatocellular carcinoma xenografts in nude mice
Wei Cui et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
Chemopreventive effect of silymarin on liver pathology in HBV X protein transgenic mice
Yi-Fang Wu et al.
CANCER RESEARCH (2008)
The role of the PTEN/AKT pathway in NOTCH1-induced leukemia
Teresa Palomero et al.
CELL CYCLE (2008)
Silymarin in the treatment of chronic liver diseases: past and future
János Fehér et al.
ORVOSI HETILAP (2008)
Effects and mechanisms of silibinin on human hepatoma cell lines
John J. Lah et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2007)
Activation of PI3K-Akt signaling pathway promotes prostate cancer cell invasion
Sanjeev Shulkla et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Milk thistle nomenclature: Why it matters in cancer research and pharmacokinetic studies
David J. Kroll et al.
INTEGRATIVE CANCER THERAPIES (2007)
Silymarin causes caspases activation and apoptosis in K562 leukemia cells through inactivation of Akt pathway
Xian Zhong et al.
TOXICOLOGY (2006)
Silibinin inhibits invasion of oral cancer cells by suppressing the MAPK pathway
PN Chen et al.
JOURNAL OF DENTAL RESEARCH (2006)
Silibinin protects rat cardiac myocyte from isoproterenol-induced DNA damage independent on regulation of cell cycle
Bei Zhou et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2006)
Silibinin efficacy against human hepatocellular carcinoma
L Varghese et al.
CLINICAL CANCER RESEARCH (2005)
Nicotine inhibits human gingival fibroblast migration via modulation of Rac signalling pathways
YY Fang et al.
JOURNAL OF CLINICAL PERIODONTOLOGY (2005)
Nuclear-cytoplasmic partitioning of phosphatase and tensin homologue deleted on chromosome 10 (PTEN) differentially regulates the cell cycle and apoptosis
JH Chung et al.
CANCER RESEARCH (2005)
Silymarin protects pancreatic beta-cells against cytokine-mediated toxicity: Implication of c-Jun NH2-terminal kinase and Janus kinase/signal transducer and activator of transcription pathways
T Matsuda et al.
ENDOCRINOLOGY (2005)
Silibinin inhibits the invasion of human lung cancer cells via decreased productions of urokinase-plasminogen activator and Matrix metalloproteinase-2
SC Chu et al.
MOLECULAR CARCINOGENESIS (2004)
A cancer chemopreventive agent silibinin, targets mitogenic and survival signaling in prostate cancer
RP Singh et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2004)
PI3K/Akt and apoptosis: size matters
TF Franke et al.
ONCOGENE (2003)
Silibinin upregulates the expression of cyclin-dependent kinase inhibitors and causes cell cycle arrest and apoptosis in human colon carcinoma HT-29 cells
C Agarwal et al.
ONCOGENE (2003)
Silymarin increases antioxidant enzymes in alloxan-induced diabetes in rat pancreas
C Soto et al.
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-TOXICOLOGY & PHARMACOLOGY (2003)
Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomas
K Kurose et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
分享论文
